Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer
Isabel Heidegger(Innsbruck Medical University), Andreas Pircher(Innsbruck Medical University)
Cited by 177
Related Papers
Overcoming immunotherapy resistance in non-small cell lung cancer (NSCLC) - novel approaches and future outlook
|Molecular Cancer|2020|300
Diverse Functions of IGF/Insulin Signaling in Malignant and Noncancerous Prostate Cells: Proliferation in Cancer Cells and Differentiation in Noncancerous Cells
|Endocrinology|2012|49
KDM5D predicts response to docetaxel chemotherapy in metastatic castration resistant prostate cancer patients
|Translational Andrology and Urology|2021|9